Application no. and date | 01925354.1 (espacenet) (Federated) (European Patent Register), 20010221 | Patent/reg. no. and date | DK/EP 1265862, 20050921 | Publication date | 20021218 | Priority no. and date | GB 0004297, 20000223 | EP pub. no. and date |
EP 1265862 20021218 | Effective date | | Applicant/owner | UCB Pharma S.A., Allee de la Recherche 60
1070 Brussels, BE | Applicant ref. no. | 109871 | Inventor | DIFFERDING, Edmond, 55, route de Blocry
B-1348 Louvain-la-Neuve, BE, LALLEMAND, Bénédicte, Remonval 11
B-4950 Waimes, BE, MATAGNE, Alain, Allée des Sorbiers 3
B-6280 Gerpinnes, BE, MICHEL, Philippe, Stoofstraat 15
B-1650 Beersel, BE, TALAGA, Patrice, Avenue E. Van Becelaere 24 A
B-1170 Watermael-Boitsfort, BE, KENDA, Benoît, Trieux des Frênes 5
B-5080 Emines, BE, PASAU, Patrick, Rue François Massart 9
B-1450 Chastre, BE | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | C07D 207/27 (2006.01) | Title | 2-oxo-1-pyrrolidinderivater, fremgangsmåder til fremstilling heraf og deres anvendelse | Int. application no. | EP2001001992 | Int. publication no. | WO2001062726 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|